Difference between revisions of "Ecstasy (MDMA)"

From WikEM
Jump to: navigation, search
(Agitation)
Line 2: Line 2:
 
==Background==
 
==Background==
 
*3,4-methylenedioxymethamphetamine (MDMA)  
 
*3,4-methylenedioxymethamphetamine (MDMA)  
*other names: E, X, XTC, Adam, Stacy
+
*Also known as: X, Molly, Skittles, Smartees, Beans
*causes catecholamine release, serotonin release, and inhibits serotonin re-uptake  
+
*Popular at "rave" parties and EDM festivals
*"rave" parties
+
*Causes catecholamine release, serotonin release, and inhibits serotonin re-uptake  
 
*1-2mg/kg effective dose; onset 30min-1 hour, peak 4 hours, lasts 8-24 hours  
 
*1-2mg/kg effective dose; onset 30min-1 hour, peak 4 hours, lasts 8-24 hours  
*typical tablets;contain 50-100mg of ecstatsy (although other substances possible)
+
**Typical tablets contain 50-100mg of MDMA
  
 
==Clinical Features==
 
==Clinical Features==
*Most people report euphoria
+
*Euphoria
 
*[[altered mental status]]  
 
*[[altered mental status]]  
*agitation
+
*Agitation
*tachycardia, palpitations, hypertension  
+
*Tachycardia, palpitations, hypertension  
 
*[[Serotonin Syndrome]] ([[altered mental status]], [[Hyperthermia]], rigidity, autonomic instability)
 
*[[Serotonin Syndrome]] ([[altered mental status]], [[Hyperthermia]], rigidity, autonomic instability)
 
*rhabdomyolysis, myoglobinuria  
 
*rhabdomyolysis, myoglobinuria  
Line 25: Line 25:
 
*Hepatotoxicity<ref>Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F. Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol. 2010;11(5):476-95</ref>
 
*Hepatotoxicity<ref>Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F. Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol. 2010;11(5):476-95</ref>
  
==Workup==
+
==Differential Diagnosis==
 +
{{Sympathomimetic types}}
 +
 
 +
==Evaluation==
 
{{Hallucinogen workup}}
 
{{Hallucinogen workup}}
*Urine tox fails to detect unless large doeses
+
*Urine tox fails to detect unless large doses
 
**More usually positive test for amphetamines
 
**More usually positive test for amphetamines
 
**Confirmation must use specialized lab tests (gas chromatography)
 
**Confirmation must use specialized lab tests (gas chromatography)
*[[Chest pain]] work up if applicable
 
*Blood and urine cultures if signs of infection
 
 
==Differential Diagnosis==
 
{{Sympathomimetic types}}
 
  
 
==Management==
 
==Management==
Line 76: Line 74:
  
 
==Disposition==
 
==Disposition==
*Admit patient's with complications of ingestion
+
*Consider discharge if all symptoms resolve and no complications noted
*Discharge those who are asymptomatic and no life threatening complication
+
*Otherwise admit
  
 
==References==
 
==References==
<references />
+
<references/>
  
 
==See Also==
 
==See Also==

Revision as of 23:58, 9 May 2017

MDMA

Background

  • 3,4-methylenedioxymethamphetamine (MDMA)
  • Also known as: X, Molly, Skittles, Smartees, Beans
  • Popular at "rave" parties and EDM festivals
  • Causes catecholamine release, serotonin release, and inhibits serotonin re-uptake
  • 1-2mg/kg effective dose; onset 30min-1 hour, peak 4 hours, lasts 8-24 hours
    • Typical tablets contain 50-100mg of MDMA

Clinical Features

Differential Diagnosis

Sympathomimetics

Evaluation

  • Urine pregnancy
  • CBC, Metabolic panel, LFTs, coags, APAP level, ASA level
  • Total CK level
  • ECG
  • UA
  • Tox screen, blood alcohol
  • Serum osmoles, urine Na (if Hyponatremia present)
  • Head CT as indicated
  • LP to rule out Meningitis if infectious symptoms and based on history and physical
  • Urine tox fails to detect unless large doses
    • More usually positive test for amphetamines
    • Confirmation must use specialized lab tests (gas chromatography)

Management

Prehospital

  • Primary focus should be on controlling agitation as well as ABCs

ABCs

  • IV, O2, monitor
  • Airway: Intubate if necessary
  • Breathing: not expected to cause hypoxia, consider other dx or concurrent problem (aspiration PNA)
  • Circulation: severe hypertension
    • benzodiazepines first line
    • Consider nitroprusside or phentolamine, avoid beta blockers (unopposed alpha stimulation)

Agitation

  • Sedation with Benzodiazepines as needed
  • Avoid Haldol, interferes with heat dissipation, may prolong QTc, may reduce seizure threshold

Seizure

Seizure AND Hyponatremia

  • Adults: 3% NS 100cc bolus over 10min; repeat after 10min x1 if no improvement[3]
    • Each 100 ml will raise sodium by ~2 mmol/l
    • In general, 200-400 mL of 3% NaCl is reasonable dose in most adult patients with severe symptomatic hyponatremia, which may be given IV over 1-2 hr until resolution of seizures.
  • Pediatrics: 2 cc/kg of 3% over 10-60 minutes can be infused with a repeat of up to 3 times.[4]
  • Goal should be to raise serum Na by 3-5 meq/L)

Hyponatremia

  • Fluids restrict most patients, unless hypovolemic.
  • Correct Na slowly: 0.5 meq/h; 10-12 meq/24h

Hyperthermia

  • Ice packs, cold IVF,
  • Rhabdomyolysis
    • Foley, IVF, goal urine output > 2cc/kg

Gastrointestinal decontamination

  • Activated charcoal for recent ingestion (< 1 hour)
  • Patient must be protecting airway or intubated

Disposition

  • Consider discharge if all symptoms resolve and no complications noted
  • Otherwise admit

References

  1. Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. J Psychopharmacol. 2012;26(3):408-18
  2. Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F. Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol. 2010;11(5):476-95
  3. Spasovski et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 0: 1–39. fulltext
  4. Moritz ML, Ayus JC. 100cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010 Mar; 25(1): 91-6.

See Also